Since the early stages of my career, I have been truly interested in understanding how PEGylation of nanocarriers can influence their diffusion across mucosal barriers, access to the lymphatics, and diffusion across tissues. Ruxandra Gref, Justin Hanes, and many others have made incredible contributions in this field. I hope this note published in DDTR serves as inspiration for you. A journey through the history of PEGylated drug delivery nanocarriers: https://lnkd.in/d6PwUB84
Excited to share our insights on the history and potential of PEGylated drug delivery nanocarriers in this inspirational note for Drug Delivery and Translational Research. Collaborating with esteemed co-authors Ruxandra Gref and Maria Jose Alonso was inspiring. #PharmaceuticalTechnology #DrugDelivery #Nanomedicine #PEG https://lnkd.in/dqxEa3qM
Thank you Maria Jose Alonso and Ana M. López Estévez for sharing. It’s truly an “inspirational note” on the history of PEGylated nano drug delivery systems. I enjoyed reading it, and already shared it with my students and colleagues!
Thanks for sharing!
Professor @ Harvard University | Hiller Professor of Bioengineering | Hansjorg Wyss Professor of Biologically Inspired Engineering | Wyss Institute
1moGreat historical perspective on PEGylation. A must read for the researchers in the field. Congratulations!